Danone Takes Cues From Pharma Marketing as GLP-1 Changes American Appetites

What’s actually driving the protein boom?

There’s a quiet transformation underway in how we eat. It’s not being led by chefs, influencers, or climate activists. It’s being driven by a new class of pharmaceuticals that are changing the way millions of people relate to food itself. GLP-1 drugs like Ozempic and Wegovy work by altering hunger signals in the brain. These medications don’t just help people feel full sooner. They are reshaping consumption patterns across the board. When hunger…

Danone takes cues from pharma marketing as GLP-1 changes American appetites

Danone brand Oikos has begun to take hints from the healthcare and pharma industry’s approach to marketing.

The pharma marketing of GLP-1 influences Danone, resulting in a shift in American appetites

New products from food and beverage brands are being launched to tackle the concerns surrounding the usage of GLP-1 weight-loss products such as...

Cigna, Novo offer lower GLP-1 prices to lure patients to brand-name drugs

Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers working with its pharmacy benefit manager. Under the new benefit, insured patients’ costs would be capped at $200 a month for both Wegovy and Zepbound.